March Biosciences Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$28.4M
- Investors
-
15
March Biosciences General Information
Description
Developer of cell-based therapies designed for the treatment of hematological cancers. The company integrates biologically informed target selection with simplified, gene-editing-free CAR-T engineering and a streamlined manufacturing process that emphasizes cell functionality and consistency, enabling oncology researchers to access novel therapeutic approaches for malignancies that lack effective targeted treatments.
Contact Information
Website
www.march.bioCorporate Office
- 7255 Helix Park Avenue
- Suite 300
- Houston, TX 77021
- United States
Corporate Office
- 7255 Helix Park Avenue
- Suite 300
- Houston, TX 77021
- United States
March Biosciences Timeline
March Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 03-Jan-2025 | $28.4M | Completed | Clinical Trials - Phase 2 | ||
| 2. Grant | 17-Nov-2023 | Completed | Clinical Trials - Phase 2 | |||
| 1. Early Stage VC (Series A) | 09-Nov-2023 | $4.8M | $4.8M | Completed | Clinical Trials - Phase 2 |
March Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
March Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
March Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
March Biosciences Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| 4BIO Capital | Venture Capital | Minority | ||
| CANCER FUND | Venture Capital | Minority | ||
| Fitz Gate Ventures | Venture Capital | Minority | ||
| Mansueto Investments | Corporation | Minority | ||
| Volnay | VC-Backed Company | Minority |
March Biosciences FAQs
-
When was March Biosciences founded?
March Biosciences was founded in 2021.
-
Where is March Biosciences headquartered?
March Biosciences is headquartered in Houston, TX.
-
What is the size of March Biosciences?
March Biosciences has 7 total employees.
-
What industry is March Biosciences in?
March Biosciences’s primary industry is Drug Discovery.
-
Is March Biosciences a private or public company?
March Biosciences is a Private company.
-
What is the current valuation of March Biosciences?
The current valuation of March Biosciences is .
-
What is March Biosciences’s current revenue?
The current revenue for March Biosciences is .
-
How much funding has March Biosciences raised over time?
March Biosciences has raised $33.2M.
-
Who are March Biosciences’s investors?
4BIO Capital, CANCER FUND, Fitz Gate Ventures, Mansueto Investments, and Volnay are 5 of 15 investors who have invested in March Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
